BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24493731)

  • 1. BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of Ota.
    Muñoz-Hidalgo L; Lopez-Gines C; Navarro L; Callaghan RC; San Miguel T; Gil-Benso R; Quilis V; Botella L; Gonzalez-Darder J; Cerda-Nicolas M
    J Clin Oncol; 2014 Jul; 32(20):e72-5. PubMed ID: 24493731
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
    Turner DJ; Zirvi MA; Barany F; Elenitsas R; Seykora J
    J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate-grade meningeal melanocytoma associated with nevus of Ota: a case report and review of the literature.
    Shin D; Sinha M; Kondziolka DS; Kirkwood JM; Rao UN; Tarhini AA
    Melanoma Res; 2015 Aug; 25(4):273-8. PubMed ID: 25933209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent intracranial melanocytoma associated with a nevus of Ota.
    Rutten I; Bolle S; Kaschten B; Stevenaert A; Deneufbourg JM; Deprez M
    Acta Neurochir (Wien); 2005 Mar; 147(3):313-5; discussion 315. PubMed ID: 15618991
    [No Abstract]   [Full Text] [Related]  

  • 6. Intracranial meningeal melanocytoma associated with nevus of Ota.
    Pan H; Wang H; Fan Y
    J Clin Neurosci; 2011 Nov; 18(11):1548-50. PubMed ID: 21924617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningeal Melanocytoma Associated with Nevus of Ota: Analysis of Twelve Reported Cases.
    Kuo KL; Lin CL; Wu CH; Chang CH; Tsai HP; Loh JK; Lieu AS; Su YF
    World Neurosurg; 2019 Jul; 127():e311-e320. PubMed ID: 30904806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
    Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
    Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis.
    Wu J; Rosenbaum E; Begum S; Westra WH
    Am J Dermatopathol; 2007 Dec; 29(6):534-7. PubMed ID: 18032947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar meningeal melanocytoma associated with nevus of Ota: An extremely rare case.
    Chen H; Liu W; Zhang S; Xu J; Hui X
    Neurology; 2015 Aug; 85(6):555-6. PubMed ID: 26259856
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nevus of Ota and benign cutaneous blue nevus associated with malignant cerebromeningeal melanoma].
    Amici JM; Vidal J; Bernard P; Negrier P; Bedane C; Bonnetblanc JM
    Ann Dermatol Venereol; 1991; 118(10):707-9. PubMed ID: 1781589
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
    Takata M; Murata H; Saida T
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
    Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAFE600-associated senescence-like cell cycle arrest of human naevi.
    Michaloglou C; Vredeveld LC; Soengas MS; Denoyelle C; Kuilman T; van der Horst CM; Majoor DM; Shay JW; Mooi WJ; Peeper DS
    Nature; 2005 Aug; 436(7051):720-4. PubMed ID: 16079850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of the eyelid and bulbar conjunctiva in a patient with nevus of Ota.
    Trindade F; Cabeçadas J; Rosa J
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):618-20. PubMed ID: 18410621
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse melanosis cutis in the setting of BRAF(V600E) metastatic melanoma.
    Sebaratnam DF; Martin LK; Venugopal SS; Mangos G; Freiman J; de Souza P; Farnsworth A; Cheung K; Scolyer RA; Murrell DF
    Int J Dermatol; 2014 Nov; 53(11):1409-11. PubMed ID: 25257244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
    Dadzie OE; Yang S; Emley A; Keady M; Bhawan J; Mahalingam M
    Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nevus of Ota associated with chronic glaucoma].
    Pal E; Chaine G; Hershkovitch D; Laroche L; Dallot A; Amouroux J
    J Fr Ophtalmol; 1997; 20(10):771-4. PubMed ID: 9587592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital melanocytoma completely resected with conservative surgery in association with ipsilateral nevus of Ota: report of a case and review of the literature.
    Tregnago AC; Furlan MV; Bezerra SM; Porto GC; Mendes GG; Henklain JV; Pinto CA; Kowalski LP; de Carvalho GB; Costa FD
    Head Neck; 2015 Apr; 37(4):E49-55. PubMed ID: 24989678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma.
    Devitt B; Liu W; Salemi R; Wolfe R; Kelly J; Tzen CY; Dobrovic A; McArthur G
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):666-72. PubMed ID: 21615881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.